1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole

We are 1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole CAS:68055-81-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole
CAS.NO:67085-12-5、68055-81-2
Synonyms:1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole
1-[2-Chloro-4-(4-Chlorophenyl)-Butyl]-Imidazol-
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 442.6±40.0 °C at 760 mmHg
Molecular Formula C13H14Cl2N2
Molecular Weight 269.170
Flash Point 221.5±27.3 °C
 
Specification:
Appearance:White Powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Butoconazole 

1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole


Related News: Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.Tetrakis(butoxyethoxy)silane CAS:18765-38-3 You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.3,5-difluorobenzonitrilo CAS:64248-63-1 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.Ácido (E) -3- (5-nitrociclohexen-1-il) prop-2-enoico CAS:899809-64-4 Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.

Related Products
Product Name
9-(4-broMophenyl)-10-(naphthalen-1-yl)anthracene View Details
Bromocyclohexane View Details
3-(5-bromo-2-phenylmethoxyphenyl)-3-phenylpropan-1-ol View Details
3-(Trifluoromethyl)benzyl bromide manufacturer Diphenyl(piperidin-4-yl)methanol manufacturer 2-BROMO-6-FLUOROANILINE manufacturer 1-(p-Toluenesulfonyl)-3-nitro-1,2,4-triazole manufacturer 2-Bromo-5-trifluoromethylphenol manufacturer